Intraoperative Sedatives and Postoperative Deilirium

NACompletedINTERVENTIONAL
Enrollment

748

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

October 15, 2021

Study Completion Date

October 15, 2021

Conditions
Lower Extremity ProblemDeliriumPropofolDexmedetomidine
Interventions
DRUG

Propofol

Propofol is infused continuously via the target-controlled infusion device (Orchestra®, Fresenius vial, Brezins, France), and the effect-site concentration is maintained within 0.5-2.0 μg/ml.

DRUG

Dexmedetomidine

Dexmedetomidine is diluted with 0.9% saline to make a concentration of 4 μg/ml. As a loading dose, 1 μg/kg dexmedetomidine is administered over a 10-min period, which is then administered continuously at 0.1-0.5 μg/kg/h.

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT03251651 - Intraoperative Sedatives and Postoperative Deilirium | Biotech Hunter | Biotech Hunter